Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Generation and preclinical characterization of an antibody specific for SEMA4D.

Fisher TL, Reilly CA, Winter LA, Pandina T, Jonason A, Scrivens M, Balch L, Bussler H, Torno S, Seils J, Mueller L, Huang H, Klimatcheva E, Howell A, Kirk R, Evans E, Paris M, Leonard JE, Smith ES, Zauderer M.

MAbs. 2016;8(1):150-62. doi: 10.1080/19420862.2015.1102813. Epub 2015 Oct 2.

2.

CXCL13 antibody for the treatment of autoimmune disorders.

Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, Smith ES, Zauderer M.

BMC Immunol. 2015 Feb 12;16:6. doi: 10.1186/s12865-015-0068-1.

3.

Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease.

Southwell AL, Franciosi S, Villanueva EB, Xie Y, Winter LA, Veeraraghavan J, Jonason A, Felczak B, Zhang W, Kovalik V, Waltl S, Hall G, Pouladi MA, Smith ES, Bowers WJ, Zauderer M, Hayden MR.

Neurobiol Dis. 2015 Apr;76:46-56. doi: 10.1016/j.nbd.2015.01.002. Epub 2015 Feb 3.

4.

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.

Evans EE, Jonason AS Jr, Bussler H, Torno S, Veeraraghavan J, Reilly C, Doherty MA, Seils J, Winter LA, Mallow C, Kirk R, Howell A, Giralico S, Scrivens M, Klimatcheva K, Fisher TL, Bowers WJ, Paris M, Smith ES, Zauderer M.

Cancer Immunol Res. 2015 Jun;3(6):689-701. doi: 10.1158/2326-6066.CIR-14-0171. Epub 2015 Jan 22.

5.

SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.

Smith ES, Jonason A, Reilly C, Veeraraghavan J, Fisher T, Doherty M, Klimatcheva E, Mallow C, Cornelius C, Leonard JE, Marchi N, Janigro D, Argaw AT, Pham T, Seils J, Bussler H, Torno S, Kirk R, Howell A, Evans EE, Paris M, Bowers WJ, John G, Zauderer M.

Neurobiol Dis. 2015 Jan;73:254-68. doi: 10.1016/j.nbd.2014.10.008. Epub 2014 Oct 18.

6.

DNA polymerase beta is critical for mouse meiotic synapsis.

Kidane D, Jonason AS, Gorton TS, Mihaylov I, Pan J, Keeney S, de Rooij DG, Ashley T, Keh A, Liu Y, Banerjee U, Zelterman D, Sweasy JB.

EMBO J. 2010 Jan 20;29(2):410-23. doi: 10.1038/emboj.2009.357. Epub 2009 Dec 17.

7.

C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.

Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M.

Mol Cancer Ther. 2006 Nov;5(11):2919-30.

8.

DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.

Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A.

PLoS Biol. 2004 Nov;2(11):e362. Epub 2004 Oct 5.

9.

Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.

Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A.

PLoS Biol. 2004 Nov;2(11):e327. Epub 2004 Oct 5.

10.

Interaction of DNA polymerase beta with GRIP1 during meiosis.

Jonason AS, Baker SM, Sweasy JB.

Chromosoma. 2001 Nov;110(6):402-10. Epub 2001 Sep 12.

PMID:
11734998
11.

Frequent clones of p53-mutated keratinocytes in normal human skin.

Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14025-9.

12.

Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion.

Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ.

J Investig Dermatol Symp Proc. 1996 Apr;1(2):136-42. Review.

PMID:
9627707
13.

Tumor suppressor gene mutations and photocarcinogenesis.

Ziegler A, Jonason A, Simon J, Leffell D, Brash DE.

Photochem Photobiol. 1996 Apr;63(4):432-5. Review. No abstract available.

PMID:
8934758
14.

Sunburn and p53 in the onset of skin cancer.

Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE.

Nature. 1994 Dec 22-29;372(6508):773-6.

PMID:
7997263
15.

Complications of burn injury.

Jonason AM.

Occup Health Nurs. 1983 Jul;31(7):24-8. No abstract available.

PMID:
6554571

Supplemental Content

Loading ...
Support Center